Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction Focusing on the Impact on the Quality of Life: A Systematic Review and Meta-Analysis of Randomized Clinical Trials-Reference-Cited by-同舟云学术

Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction Focusing on the Impact on the Quality of Life: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Published:2023-11-11 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Bhattacharjee Priyadarshini,Khan Zahid

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference71 articles.

1. Congestive heart failure;Malik A,2022

2. Heart failure with mid-range ejection fraction - a new category of heart failure or still a gray zone;Andronic AA;Maedica (Bucur),2016

3. Epidemiology and aetiology of heart failure;Ziaeian B;Nat Rev Cardiol,2016

4. Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings;Lind L;Open Heart,2021

5. High-output heart failure: a 15-year experience;Reddy YN;J Am Coll Cardiol,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of cardiovascular risk and physical activity: the role of cardiac-specific biomarkers in the general population and athletes;Clinical Chemistry and Laboratory Medicine (CCLM);2024-07-18

2. Benefits of sacubitril/valsartan administration and physical training in cardiac rehabilitation: current trends and bibliometric analysis of the years 2015-2024;Balneo and PRM Research Journal;2024-06-21

3. A Retrospective Study of Whether Sacubitril–Valsartan Improves Cardiac Function in Patients with Acute Coronary Syndrome and Hypertension after Percutaneous Coronary Intervention;The Heart Surgery Forum;2024-06-17